China’s push to industrialise humanoid robotics took a significant step forward as Eyou Robot Technology opened what it describes as the world’s first fully automated production line dedicated to humanoid robot joints. The facility, located in Shanghai’s Pudong district, is designed to support
A new round of state level restrictions in the United States is adding friction to already complex technology relations with China, as Texas moves to bar government employees from using products linked to several major Chinese firms. The decision, announced by Texas Governor
China’s rapid expansion in robotics is often interpreted as a singular drive toward automation leadership. This view, while partially accurate, misses the deeper policy logic shaping how and where robots are being deployed. Rather than prioritizing speed or scale alone, China’s robotics strategy
China’s cybersecurity approach is undergoing a quiet but meaningful transformation. For much of the past decade, digital security policy was widely interpreted through the lens of information control and regulatory enforcement. While governance and oversight remain central, recent developments suggest that system continuity
From regulatory obligation to systemic function Cybersecurity in China is undergoing a conceptual shift. What was once treated primarily as a compliance requirement is increasingly recognized as a foundational component of national infrastructure. As digital systems permeate finance, manufacturing, energy, transport, and public
From rapid expansion to measured growth China’s tech startup landscape is entering a phase defined less by rapid expansion and more by disciplined execution. The earlier era of abundant capital and growth at all costs has given way to tighter funding conditions and
Automation moves from scale to sophistication China’s manufacturing sector has long relied on automation to support scale and cost efficiency. Industrial robotics adoption now reflects a shift toward sophistication rather than simple mechanization. Robots are increasingly deployed not only to replace manual labor,
From trial and error to data driven discovery Drug discovery has traditionally been a slow and uncertain process shaped by trial and error. In China, artificial intelligence is changing this dynamic by introducing data driven methods that compress research timelines and improve decision
Artificial intelligence (AI) is increasingly transforming healthcare in China, reshaping hospital operations, diagnostics, treatment planning, and patient management. By leveraging advanced algorithms, big data analytics, and machine learning models, hospitals are improving efficiency, enhancing clinical accuracy, and delivering more personalized care. This integration
Mandi’s IPO plan arrives at a time when Hong Kong’s capital markets are experiencing a remarkable revival. According to data from the London Stock Exchange Group, equity capital activity in the city has reached around seventy three billion dollars so far this year,
